The relevance of cardiovascular role played by levels of serum uric acid is dramatically growing, especially as cardiovascular risk factor potentially able to exert either a direct deleterious impact or a synergic effect with other cardiovascular risk factors. At the present time, it still remains undefined the threshold level of serum uric acid able to contribute to the cardiovascular risk. Indeed, the available epidemiological case studies are not homogeneous, and some preliminary data suggest that the so-called "cardiovascular threshold limit" may substantially differ from that identified as a cut-off able to trigger the acute gout attack. In such scenario, there is the necessity to clarify and quantify this threshold value, to insert it in the stratification of risk algorithm scores and, in turn, to adopt proper prevention and correction strategies. The clarification of the relationship between circulating levels of uric acid and cardio-nephro-metabolic disorders in a broad sample representative of general population is critical to identify the threshold value of serum uric acid better discriminating the increased risk associated with uric acid. The Uric acid Right for heArt Health (URRAH) project has been designed to define, as primary objective, the level of uricemia above which the independent risk of cardiovascular disease may increase in a significantly manner in a general Italian population.

Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study / Desideri, Giovambattista; Virdis, Agostino; Casiglia, Edoardo; Borghi, Claudio; Cicero, Afg; Muiesan, Ml; Rosei, Ea; Salvetti, M; Ungar, A; Rivasi, G; Pontremoli, R; Viazzi, F; Desideri, G; Grassi, G; Bombelli, M; Facchetti, R; Ferri, C; Bernardino, B; Galletti, F; D'Elia, L; Palatini, P; Casiglia, E; Tikhonoff, V; Barbagallo, Cm; Verdecchia, P; Virdis, Pietrina; Masi, S; Mallamaci, F; Cirillo, M; Rattazzi, M; Pauletto, P; Cirillo, P; Gesualdo, L; Mazza, A; Giannattasio, C; Maloberti, A; Volpe, M; Tocci, G; Iaccarino, G; Nazzaro,. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - 25:2(2018), pp. 197-202. [10.1007/s40292-018-0250-7]

Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study

Galletti F;D'Elia L;Virdis, Pietrina;Cirillo M;Iaccarino G;
2018

Abstract

The relevance of cardiovascular role played by levels of serum uric acid is dramatically growing, especially as cardiovascular risk factor potentially able to exert either a direct deleterious impact or a synergic effect with other cardiovascular risk factors. At the present time, it still remains undefined the threshold level of serum uric acid able to contribute to the cardiovascular risk. Indeed, the available epidemiological case studies are not homogeneous, and some preliminary data suggest that the so-called "cardiovascular threshold limit" may substantially differ from that identified as a cut-off able to trigger the acute gout attack. In such scenario, there is the necessity to clarify and quantify this threshold value, to insert it in the stratification of risk algorithm scores and, in turn, to adopt proper prevention and correction strategies. The clarification of the relationship between circulating levels of uric acid and cardio-nephro-metabolic disorders in a broad sample representative of general population is critical to identify the threshold value of serum uric acid better discriminating the increased risk associated with uric acid. The Uric acid Right for heArt Health (URRAH) project has been designed to define, as primary objective, the level of uricemia above which the independent risk of cardiovascular disease may increase in a significantly manner in a general Italian population.
2018
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study / Desideri, Giovambattista; Virdis, Agostino; Casiglia, Edoardo; Borghi, Claudio; Cicero, Afg; Muiesan, Ml; Rosei, Ea; Salvetti, M; Ungar, A; Rivasi, G; Pontremoli, R; Viazzi, F; Desideri, G; Grassi, G; Bombelli, M; Facchetti, R; Ferri, C; Bernardino, B; Galletti, F; D'Elia, L; Palatini, P; Casiglia, E; Tikhonoff, V; Barbagallo, Cm; Verdecchia, P; Virdis, Pietrina; Masi, S; Mallamaci, F; Cirillo, M; Rattazzi, M; Pauletto, P; Cirillo, P; Gesualdo, L; Mazza, A; Giannattasio, C; Maloberti, A; Volpe, M; Tocci, G; Iaccarino, G; Nazzaro,. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - 25:2(2018), pp. 197-202. [10.1007/s40292-018-0250-7]
File in questo prodotto:
File Dimensione Formato  
2018 HBP&CVP protocollo URRAH.pdf

non disponibili

Descrizione: pdf pre-print
Tipologia: Documento in Pre-print
Licenza: Accesso privato/ristretto
Dimensione 303.52 kB
Formato Adobe PDF
303.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/709560
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 29
social impact